G astroparesis is a chronic gastrointestinal (GI) disorder defined by delayed stomach emptying in the absence of obstruction [1] [2] [3] [4] and associated with symptoms of nausea, vomiting, abdominal pain, early satiety, and bloating. [1] [2] [3] [5] [6] [7] [8] The most common causes of gastroparesis are diabetes mellitus (DM), postsurgical complications, and idiopathic or postinfectious processes. 9, 10 In the community setting, 5% to 12% of patients with diabetes present with symptoms attributable to gastroparesis, 11, 12 and in academic settings, diabetes can represent nearly one-third of gastroparesis patients. 9 Because of the high overlap between symptoms of gastroparesis and other common GI disorders, diagnosis requires documentation of delayed emptying on a gastric emptying scan. [13] [14] [15] Few safe and effective treatment options are currently available to manage the symptoms of gastroparesis. 3, 8 Gastroparesis seems to be relatively uncommon, with the age-adjusted incidence per 100,000 persons estimated at 9.6 for men and 37.8 for women. 16 Gastroparesis is associated with increased health care burden and notably reduced health-related quality of life. [17] [18] [19] A significant portion of the economic burden associated with gastroparesis relates to emergency department (ED) and hospitalization costs. In a recent outpatient survey study, nearly 54% of gastroparesis patients reported having visited the ED in the past year due to symptom exacerbation. 20 Similarly, a retrospective, single-center study of 326 gastroparesis patients followed from 2004 to 2008 found that nearly one-third of the patients required hospitalizations for symptom exacerbations or nutritional support each year. 21 The most recent analysis of a representative sample of the US population found that, gastroparesis-related hospitalizations in the United States increased 158% from 1995 to 2004. This was significantly greater than the rate of DM-related hospitalizations, which in the same time period only increased 53%. 22 The primary aim of this study is to provide data on nationwide ED trends in prevalence, demographics, admissions, and charges associated with gastroparesis in the United States from 2006 to 2013. A secondary aim of this study is to examine these same trends in a subset of patients with a comorbid diagnosis of DM.
MATERIALS AND METHODS
This study evaluates trends in ED visits from 2006 to 2013 by analyzing patients with a primary diagnosis of gastroparesis as well as patients with a primary diagnosis of gastroparesis plus a secondary diagnosis of DM using International Classification of Diseases, Nineth Revision (ICD-9) codes. This analysis was carried out through utilization of the Nationwide Emergency Department Sample (NEDS) from the Healthcare Cost and Utilization Project (HCUP) which is maintained by the Agency for Healthcare Research and Quality. 23, 24 Statistics on trends and demographic data are freely available through HCUPnet.
The NEDS is the largest publicly available ED allpayer database in the United States. The NEDS contains information on ∼30 million ED visits from ∼950 hospitals in the United States each year, weighted to represent the over 120 million ED visits each year. Individual years of the NEDS are available for purchase and include patient-level data on topics such as demographics, location, primary payer, income quartile, and associated costs. Information on admission rates, procedures performed, and associated charges of those admitted to the hospital from the ED are also analyzed using information contained in the NEDS.
Study Variables
For the primary aim of this study, only patients with a primary diagnosis of gastroparesis (ICD-9) code 536.3) were included, as this most accurately reflects the chief complaint for the ED visit. In secondary analyses, a subgroup of patients who received a primary diagnosis of gastroparesis and a secondary diagnosis of DM (ICD-9 code 250.XX), defined as diabetic gastroparesis, was identified and analyzed separately.
For descriptive and comparative purposes, we examined trends in patients with other GI disorders such as dyspepsia (ICD-9 787.1), gastroesophageal reflux disease (ICD-9 530.81), and nonspecific nausea and vomiting (ICD-9 787.01). We also examined a group of patients with either a primary or a secondary diagnosis of gastroparesis.
Demographic data were retrieved according to predefined categories set by HCUP such as age, sex, charge (both ED and inpatient), primary payer (Medicare, Medicaid, private-including Health Maintenance Organization, self-pay, no charge, and other), hospital region (Northeast, Midwest, South, and West), hospital location [large central metropolitan (city with > 1 million population), large fringe metropolitan (city suburb with ≥ 1 million population), medium metropolitan (metro area with 50,000 to 1 million population), and small metropolitan (metro area with ≤ 50,000 population), and household income.
Inpatient data for patients admitted through the ED with a primary diagnosis of gastroparesis include charges, procedures performed, and length of stay. Inpatient procedure data examined in this study include Endoscopy (ICD-9 45.12-45. 
Statistical Analysis
Statistical analysis was performed using STATA/SE 14.1 using the source files for the 2006 and 2013 NEDS, and all cost data reported are inflation adjusted to 2016 dollars using the Consumer Price Index inflation calculator. 25 Total charge data were obtained by multiplying the mean charge in a year by the total number of visits for a year. Rates per 100,000 ED visits were obtained by dividing the number of gastroparesis ED visits by the total number of ED visits and multiplying by 100,000.
RESULTS

ED Rates
Gastroparesis
The number of ED visits for gastroparesis as a primary diagnosis in the United States increased from 15,459 in 2006 to 36,820 in 2013, a 138% increase (Table 1 ). This represents a rise from 12.9 to 27.3 per 100,000 ED visits ( Table 1) .
The rate of rise in ED visits with a primary diagnosis of gastroparesis from 2006 to 2013 outpaced the rates for other functional upper-GI disorders such as functional dyspepsia, gastroesophageal reflux disease, and nonspecific nausea and vomiting (Fig. 1) . Moreover, the rate of rise in patients with a primary diagnosis of gastroparesis in the ED was higher than the combined rate of patients with either a primary or secondary diagnosis of gastroparesis (Fig. 2) . ‡Data may not add up to 100% due to missing data. §Large central metropolitan-city with > 1 million population; Large fringe metropolitan-city suburb with > 1 million population; Medium metropolitan-metro area with 50,000 to 1 million population; Small metropolitan-an area with ≤ 50,000 population.
CI indicates confidence interval; DM, diabetes mellitus; ED, emergency department; HMO, Health Maintenance Organization.
Diabetic Gastroparesis
The number of ED visits for patients with diabetic gastroparesis increased by 148% from 5696 in 2006 to 14,114 in 2013, representing a rise from 4.7 to 10.5 visits per 100,000 ED visits. During the same time period, the total number of DM-related ED visits (patients with a primary or secondary diagnosis of DM) rose by 45%. However, diabetic gastroparesis accounted for a stable proportion of all primary gastroparesis visits across this time frame, constituting 36.8% and 38.3% of all primary gastroparesis visits in 2006 and 2013, respectively (Table 2) .
Charges
Gastroparesis
The total combined ED and inpatient charges ( 
Admissions and Procedures
Gastroparesis
Admissions to the hospital from the ED among patients with gastroparesis as a primary diagnosis fell from 58.1% in 2006 to 36.1% in 2013 ( Table 1 ). The mean length of stay for patients admitted from the ED decreased from 5.4 to 4.8 days from 2006 to 2013 (Table 1) . The percentage of patients admitted through the ED who had a procedure performed decreased from 58.1% in 2006 to 51.9% in 2013. The rates of commonly performed procedures can be found in Table 3 .
Diabetic Gastroparesis
Patients with diabetic gastroparesis were admitted through the ED at a lower rate than those with only a primary diagnosis of gastroparesis between 2006 and 2013 from 48.5% to 28.2% ( Table 2 ). The mean length of stay for patients with diabetic gastroparesis decreased from 4.8 to 4.2 days from 2006 to 2013 (Table 2 ). In addition, the percentage of diabetic gastroparesis patients admitted to the hospital through the ED who had an inpatient procedure performed decreased from 53.8% in 2006 to 44.6% in 2013.
Demographics
Gastroparesis
The observed increased incidence of ED visits for patients with a primary diagnosis of gastroparesis was also characterized by predominantly more women. The percentage of visits by women increased from 67.3% to 70.2% and the mean age declined from 48.1 years (95% CI: 47. 
Diabetic Gastroparesis
The mean age of patients entering the ED with diabetic gastroparesis was approximately the same as patients with a primary diagnosis of gastroparesis decreasing from 49. Table 2 ). The percentage of women with diabetic gastroparesis was lower than those only with a primary gastroparesis diagnosis, but rose at a similar rate between 2006 and 2013 from 61.2% to 64.0% (Table 2) .
DISCUSSION
This study shows that the total number of ED visits for gastroparesis increased 138% from 2006 to 2013. In contrast, admission rates through the ED decreased 22%, procedure rates decreased by 6.2%, and the mean length of stay was shortened by 0.6 days. Combined ED and inpatient charges for patients with a primary diagnosis of gastroparesis increased by 107% from 2006 to 2013 compared with a rise of 46% in all ED and inpatient charges in the United States during the same time period. The number of ED visits for patients with diabetic gastroparesis increased 148%. The total associated charges with these ED visits and subsequent admissions rose 117% from about $84 million in 2006 to about $182 million in 2013.
Although the total number of ED visits for patients with a primary diagnosis of gastroparesis increased, the proportion of diabetic and nondiabetic patients was consistent from 2006 to 2013. Therefore, the increased rates of gastroparesis in the ED can be attributed to increases in both nondiabetic and diabetic gastroparesis visits. Nondiabetic gastroparesis is often attributed to postinfectious processes, postsurgical complications affecting the vagus nerve, and complications of other conditions such as anorexia nervosa. 26 Although very little is known about the natural history of gastroparesis, a study in Olmstead County showed a stable incidence of gastroparesis from 1996 to 2000 and 2001 to 2006. 16 The increases in nondiabetic gastroparesis ED visits may reflect an increased incidence of these processes, an increased awareness of idiopathic gastroparesis among emergency room providers, or both. In contrast, the increase in diabetic gastroparesis ED visits seems likely to be tied to the increasing prevalence of DM as seen in the 45% increase in all DM-related ED visits from 2006 to 2013.
It is worth noting that the rate of inpatient admission for gastroparesis from the ED fell from 58% in 2006 to 36% in 2013 and the mean length of stay decreased by 0.6 days. This is in contrast to a prior study which reported increasing admission rates from the ED for gastroparesis and increasing length of stay for these visits from 1995 to 2004. 22 Mean ED charges for gastroparesis patients were higher than the national mean for all ED charges; however their mean inpatient charges were lower than the national mean. This may be attributable to a shift in gastroparesis care in the ED to an outpatient setting. A significant increase in charges may be due to an increasing use of prokinetic and antiemetic drugs as well as increasing nursing staff resources utilized in caring for these patients in the ED.
One reason for the smaller rate of increase in inpatient charges compared with ED charges in the care of gastroparesis patients is the simultaneous decline in inpatient procedure performed. Similar to a prior study, upper endoscopic procedures occurred in a third of admissions. 27 However, radiology, colonoscopy, and vascular catheterizations show a decreasing trend in from 2009 to 2013. This may indicate less patient complexity or providers choosing less costly interventions that may not be warranted. This is reasonable given the evidence indicating fewer than 5% of nontherapeutic endoscopies result in a change in treatment, and fewer than one-sixth of computed tomographic scans identify relevant findings in gastroparesis. 21 The South had a disproportionately high rate of gastroparesis ED visits compared with other regions in the United States. This could possibly be tied to the high rates of DM and low income levels, which are both tied to increased ED visits. Consistent with this trend, the percentage of patients in the bottom quartile of household income saw the largest increase between 2006 and 2013.
There are several limitations to this study. As symptoms of gastroparesis are nonspecific and given the nature of using ICD-9 billing codes as evidence of gastroparesis, we cannot confirm each instance of gastroparesis based on a gastric emptying scan. In addition, the hospitals that are included in the NEDS database may vary in their coding practices. Moreover, patients who visit the ED multiple times are counted as separate individuals. We do not account for ambulatory data or patients admitted to the hospital outside of the ED in our analysis. Despite these limitations, we believe the sample size and the fact that the NEDS is a representative database of patients in the United States outweigh these limitations.
In conclusion, this study highlights a disproportionately high rate of gastroparesis-related ED visits. Although the mean length of inpatient stay and inpatient procedure rates have decreased, ED and hospitalization charges are rising in this population. Given the demands on costs due to health care utilization and individual costs on quality of life, further research should focus on the causes of this increasing rate of gastroparesis in the ED as well as on the associated charges.
